127 related articles for article (PubMed ID: 21676127)
1. Lithium treatment attenuates muscarinic M(1) receptor dysfunction.
Creson TK; Austin DR; Shaltiel G; McCammon J; Wess J; Manji HK; Chen G
Bipolar Disord; 2011 May; 13(3):238-49. PubMed ID: 21676127
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.
Mann L; Heldman E; Bersudsky Y; Vatner SF; Ishikawa Y; Almog O; Belmaker RH; Agam G
Bipolar Disord; 2009 Dec; 11(8):885-96. PubMed ID: 19922557
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice.
Woolley ML; Carter HJ; Gartlon JE; Watson JM; Dawson LA
Eur J Pharmacol; 2009 Jan; 603(1-3):147-9. PubMed ID: 19111716
[TBL] [Abstract][Full Text] [Related]
4. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers.
Zhou R; Yuan P; Wang Y; Hunsberger JG; Elkahloun A; Wei Y; Damschroder-Williams P; Du J; Chen G; Manji HK
Neuropsychopharmacology; 2009 May; 34(6):1395-405. PubMed ID: 18704095
[TBL] [Abstract][Full Text] [Related]
5. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Watson DG; Watterson JM; Lenox RH
J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
[TBL] [Abstract][Full Text] [Related]
6. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.
Einat H; Yuan P; Gould TD; Li J; Du J; Zhang L; Manji HK; Chen G
J Neurosci; 2003 Aug; 23(19):7311-6. PubMed ID: 12917364
[TBL] [Abstract][Full Text] [Related]
7. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis.
Hao Y; Creson T; Zhang L; Li P; Du F; Yuan P; Gould TD; Manji HK; Chen G
J Neurosci; 2004 Jul; 24(29):6590-9. PubMed ID: 15269271
[TBL] [Abstract][Full Text] [Related]
8. The anterior cingulate ERK pathway contributes to regulation of behavioral excitement and hedonic activity.
Creson TK; Hao Y; Engel S; Shen Y; Hamidi A; Zhuo M; Manji HK; Chen G
Bipolar Disord; 2009 Jun; 11(4):339-50. PubMed ID: 19500087
[TBL] [Abstract][Full Text] [Related]
9. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
Chuang DM
Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
[TBL] [Abstract][Full Text] [Related]
10. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement.
Engel SR; Creson TK; Hao Y; Shen Y; Maeng S; Nekrasova T; Landreth GE; Manji HK; Chen G
Mol Psychiatry; 2009 Apr; 14(4):448-61. PubMed ID: 18227838
[TBL] [Abstract][Full Text] [Related]
11. Glutamate-mediated calcium signaling: a potential target for lithium action.
Sourial-Bassillious N; Rydelius PA; Aperia A; Aizman O
Neuroscience; 2009 Jul; 161(4):1126-34. PubMed ID: 19362133
[TBL] [Abstract][Full Text] [Related]
12. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
Smith DG; Qi H; Svenningsson P; Wade M; Davis RJ; Gehlert DR; Nomikos GG
Synapse; 2008 Feb; 62(2):128-36. PubMed ID: 18000809
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania.
Shaltiel G; Maeng S; Malkesman O; Pearson B; Schloesser RJ; Tragon T; Rogawski M; Gasior M; Luckenbaugh D; Chen G; Manji HK
Mol Psychiatry; 2008 Sep; 13(9):858-72. PubMed ID: 18332879
[TBL] [Abstract][Full Text] [Related]
15. The interaction between dopamine D2-like and beta-adrenergic receptors in the prefrontal cortex is altered by mood-stabilizing agents.
Montezinho LP; Castro MM; Duarte CB; Penschuck S; Geraldes CF; Mørk A
J Neurochem; 2006 Mar; 96(5):1336-48. PubMed ID: 16478526
[TBL] [Abstract][Full Text] [Related]
16. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
Cui J; Shao L; Young LT; Wang JF
Neuroscience; 2007 Feb; 144(4):1447-53. PubMed ID: 17184924
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
[TBL] [Abstract][Full Text] [Related]
18. Galanin up-regulates the expression of M1 muscarinic acetylcholine receptor via the ERK signaling pathway in primary cultured prefrontal cortical neurons.
Cheng Y; Yu LC
Neurosci Lett; 2015 Mar; 590():161-5. PubMed ID: 25676809
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells.
Shao L; Young LT; Wang JF
Biol Psychiatry; 2005 Dec; 58(11):879-84. PubMed ID: 16005436
[TBL] [Abstract][Full Text] [Related]
20. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
Chen G; Manji HK
Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
